lithium has been researched along with Depressive Disorder, Major in 110 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (14.55) | 18.7374 |
1990's | 2 (1.82) | 18.2507 |
2000's | 29 (26.36) | 29.6817 |
2010's | 40 (36.36) | 24.3611 |
2020's | 23 (20.91) | 2.80 |
Authors | Studies |
---|---|
Adli, M; Bopp, SK; Buspavanich, PJ; Heilbronner, U; Heinz, A; Lang, UE; Mühleisen, TW; Ricken, R; Schlattmann, P; Schulze, TG | 1 |
Ahearn, E; Boney, TY; Conrad, CH; DeLisi, LE; Doros, G; Ferguson, R; Hoffman, B; Holmberg, EF; Huang, GD; Katz, IR; Kaufman, JS; Lew, R; Liang, MH; Ostacher, MJ; Paik, JM; Ringer, RJ; Rogers, MP; Smith, EG; Thwin, SS | 1 |
Adl, M; Akiyama, K; Akula, N; Alda, M; Amare, AT; Ardau, R; Arias, B; Aubry, JM; Backlund, L; Bauer, M; Baune, BT; Bellivier, F; Benabarre, A; Bengesser, S; Bhattacharjee, AK; Biernacka, JM; Birner, A; Cearns, M; Cervantes, P; Chen, HC; Chillotti, C; Cichon, S; Clark, SR; Colom, F; Cruceanu, C; Czerski, PM; Dalkner, N; Dayer, A; Degenhardt, F; Del Zompo, M; DePaulo, JR; Étain, B; Falkai, P; Ferensztajn-Rochowiak, E; Forstner, AJ; Frank, J; Frisen, L; Frye, MA; Fullerton, JM; Gard, S; Garnham, JS; Goes, FS; Grigoroiu-Serbanescu, M; Grof, P; Hashimoto, R; Hauser, J; Heilbronner, U; Herms, S; Hoffmann, P; Hou, L; Hsu, YH; Jamain, S; Jiménez, E; Kahn, JP; Kassem, L; Kato, T; Kelsoe, J; Kittel-Schneider, S; König, B; Kuo, PH; Kusumi, I; Laje, G; Landén, M; Lavebratt, C; Leboyer, M; Leckband, SG; Maj, M; Manchia, M; Marie-Claire, C; Martinsson, L; McCarthy, MJ; McElroy, S; McMahon, FJ; Mitchell, PB; Mitjans, M; Mondimore, FM; Monteleone, P; Nievergelt, CM; Nöthen, MM; Novák, T; O'Donovan, C; Ösby, U; Ozaki, N; Papiol, S; Pfennig, A; Pisanu, C; Potash, JB; Reif, A; Reininghaus, E; Rietschel, M; Roberts, G; Rouleau, GA; Rybakowski, JK; Schalling, M; Schofield, PR; Schubert, KO; Schulze, TG; Schweizer, BW; Severino, G; Shekhtman, T; Shilling, PD; Shimoda, K; Simhandl, C; Slaney, CM; Squassina, A; Stamm, T; Stopkova, P; Streit, F; Tekola-Ayele, F; Thalamuthu, A; Tortorella, A; Turecki, G; Veeh, J; Vieta, E; Witt, SH; Zandi, PP | 1 |
Honyashiki, M; Inoue, T; Terao, I | 1 |
Adli, M; Akiyama, K; Akula, N; Alda, M; Amare, AT; Ardau, R; Arias, B; Aubry, J; Backlund, L; Bauer, M; Baune, BT; Bellivier, F; Benabarre, A; Bengesser, S; Bhattacharjee, AK; Biernacka, JM; Birner, A; Brichant-Petitjean, C; Cearns, M; Cervantes, P; Chen, H; Chillotti, C; Cichon, S; Clark, SR; Colom, F; Cruceanu, C; Czerski, PM; Dalkner, N; Dayer, A; Degenhardt, F; DePaulo, JR; Étain, B; Falkai, P; Forstner, AJ; Frank, J; Frisen, L; Frye, MA; Fullerton, JM; Gard, S; Garnham, JS; Goes, FS; Grigoroiu-Serbanescu, M; Grof, P; Hashimoto, R; Hauser, J; Heilbronner, U; Herms, S; Hoffmann, P; Hofmann, A; Hou, L; Hsu, YH; Jamain, S; Jiménez, E; Kahn, JP; Kassem, L; Kato, T; Kelsoe, J; Kittel-Schneider, S; Kliwicki, S; König, B; Kuo, PH; Kusumi, I; Laje, G; Landén, M; Lavebratt, C; Leboyer, M; Leckband, SG; Maj, M; Manchia, M; Martinsson, L; McCarthy, MJ; McElroy, S; McMahon, FJ; Millischer, V; Mitchell, PB; Mitjans, M; Mondimore, FM; Monteleone, P; Nievergelt, CM; Nöthen, MM; Novák, T; O'Donovan, C; Ozaki, N; Papiol, S; Pfennig, A; Pisanu, C; Potash, JB; Reif, A; Reininghaus, E; Rietschel, M; Roberts, G; Rouleau, GA; Rybakowski, JK; Schalling, M; Schofield, PR; Schubert, KO; Schulze, TG; Schweizer, BW; Severino, G; Shekhtman, T; Shilling, PD; Shimoda, K; Simhandl, C; Slaney, CM; Squassina, A; Stamm, T; Stopkova, P; Streit, F; TekolaAyele, F; Thalamuthu, A; Tortorella, A; Turecki, G; Veeh, J; Vieta, E; Witt, SH; Zandi, PP; Zompo, MD | 1 |
Gao, TH; Li, T; Ma, XH; Ni, PY; Ni, RJ; Tian, Y; Wang, YY; Wei, JX; Zhao, LS | 1 |
Caldieraro, MA; Feiten, JG; Géa, LP; Kauer-Sant'Anna, M; Salum, GA; Scotton, E; Silveira Júnior, ÉM; Valiati, FE | 1 |
Davis, RE; Dutheil, S; Snyder, GL; Watson, LS | 1 |
Chen, R; Davis, RE; Durgam, S; Kozauer, SG; Lakkis, HD; Mates, S; McIntyre, RS; Satlin, A; Suppes, T; Tohen, M; Vanover, KE | 1 |
Ercis, M; Ozerdem, A; Singh, B | 1 |
Ferguson, R; Hernán, MA; Katz, IR; Lew, R; Liang, MH; Madenci, A; Szmulewicz, A | 1 |
Bachu, A; Madangarli, N; Patel, RS; Youssef, NA | 1 |
Andersson, P; Desai Boström, AE; Jarbin, H; Jokinen, J; Lundberg, J | 1 |
Baldessarini, RJ; Berardelli, I; Erbuto, D; Germano, L; Pompili, M; Rogante, E; Sarli, G; Sarubbi, S | 1 |
Andersson, E; Boberg, J; Clements, CC; Jonsson, L; Karlsson, R; Kowalec, K; Landén, M; Lewis, CM; Lu, Y; Rück, C; Sigström, R; Song, J; Sullivan, PF; Xiong, Y | 1 |
Kirsch, I | 1 |
Adli, M; Akiyama, K; Akula, N; Alda, M; Amare, AT; Ardau, R; Arias, B; Aubry, JM; Backlund, L; Bauer, M; Baune, BT; Bellivier, F; Benabarre, A; Bengesser, S; Bhattacharjee, AK; Biernacka, JM; Birner, A; Brichant-Petitjean, C; Cearns, M; Cervantes, P; Chen, HC; Chillotti, C; Cichon, S; Clark, SR; Colom, F; Cruceanu, C; Czerski, PM; Dalkner, N; Dayer, A; Degenhardt, F; Del Zompo, M; DePaulo, JR; Étain, B; Falkai, P; Forstner, AJ; Frisen, L; Frye, MA; Fullerton, JM; Gard, S; Garnham, JS; Goes, FS; Grigoroiu-Serbanescu, M; Grof, P; Hashimoto, R; Hauser, J; Heilbronner, U; Herms, S; Hoffmann, P; Hofmann, A; Hou, L; Hsu, YH; Jamain, S; Jiménez, E; Kahn, JP; Kassem, L; Kato, T; Kelsoe, JR; Kittel-Schneider, S; Kliwicki, S; König, B; Kuo, PH; Kusumi, I; Laje, G; Landén, M; Lavebratt, C; Leboyer, M; Leckband, SG; Maj, M; Manchia, M; Martinsson, L; McCarthy, MJ; McElroy, SL; McMahon, FJ; Mitchell, PB; Mitjans, M; Mondimore, FM; Monteleone, P; Nievergelt, CM; Nöthen, MM; Novák, T; O'Donovan, C; Ösby, U; Ozaki, N; Papiol, S; Pfennig, A; Potash, JB; Reif, A; Reininghaus, E; Rietschel, M; Rouleau, GA; Rybakowski, JK; Schalling, M; Schofield, PR; Schubert, KO; Schulze, TG; Schweizer, BW; Severino, G; Shekhtman, T; Shilling, PD; Shimoda, K; Simhandl, C; Slaney, CM; Squassina, A; Stamm, T; Stopkova, P; Tekola-Ayele, F; Tortorella, A; Turecki, G; Veeh, J; Vieta, E; Witt, SH; Wright, A; Zandi, PP | 1 |
Cao, JL; Ding, HL; Han, MH; Hu, SW; Liu, D; Liu, H; Montgomery, SE; Song, SP; Tang, QQ; Wang, D; Wang, ZY; Xu, Z; Yang, JX; Yang, XN; Zhang, H | 1 |
Berk, M; Brietzke, E; Goldstein, BI; Kessing, LV; López-Jaramillo, C; Majeed, A; Malhi, GS; Mansur, RB; McIntyre, RS; Nierenberg, AA; Rosenblat, JD; Vieta, E; Vinberg, M; Young, AH | 1 |
Detraux, J; Lambrichts, S; Nordenskjöld, A; Obbels, J; Schrijvers, D; Sienaert, P; Vansteelandt, K | 1 |
Ågren, H; Aigner, L; Funa, K; Hanse, E; Iljin, M; Illes, S; Izsak, J; Seth, H; Theiss, S | 1 |
Hashimoto, K; Hashimoto, R; Hashimoto, T; Hata, T; Hattori, K; Hishimoto, A; Horai, T; Idemoto, K; Ishima, T; Iyo, M; Kameno, Y; Kikuchi, M; Kimura, A; Minabe, Y; Mori, N; Nakagome, K; Niitsu, T; Oda, Y; Ota, K; Otsuka, I; Toda, S; Yamamori, H; Yoshida, S | 1 |
Alexopoulos, G; Bailine, SH; Bernhardt, E; Briggs, MC; Cullum, CM; Deng, ZD; Geduldig, ET; Greenberg, RM; Husain, MM; Kaliora, S; Kellner, CH; Knapp, RG; Latoussakis, V; Liebman, LS; Lisanby, SH; McCall, WV; McClintock, SM; Mueller, M; Petrides, G; Prudic, J; Rosenquist, PB; Rudorfer, MV; Sampson, S; Teklehaimanot, AA; Tobias, KG; Weiner, RD; Young, RC | 1 |
Aljurdi, RK; Banerjee, S; Evans, LD; Gildengers, AG; Gur, RC; Gyulai, L; Marino, P; Mulsant, BH; Sajatovic, M; Schulberg, HC; Young, RC | 1 |
Hoti, F; Lähteenvuo, M; Mehtälä, J; Taipale, H; Tanskanen, A; Tiihonen, J; Vattulainen, P | 1 |
Young, AH | 1 |
Attenburrow, MJ; Cipriani, A; Cleare, AJ; Dietch, D; Geddes, J; Goldsmith, K; Holland, R; Hutchinson, J; Marwood, L; McAllister-Williams, RH; Nair, R; Pickles, A; Romeo, R; Taylor, R; Young, AH | 1 |
Daniels, PF; Hincapie-Castillo, JM | 1 |
Tiihonen, J | 1 |
Adli, M; Bauer, M; Bopp, S; Borgwardt, S; Bschor, T; Elstner, S; Heinz, A; Hellweg, R; Himmerich, H; Lang, UE; Lingesleben, A; Reischies, FM; Richter, C; Ricken, R; Schlattmann, P; Schulz-Ratei, B; Stamm, TJ; Sterzer, P | 1 |
Baldessarini, RJ; Tondo, L; Vázquez, GH | 1 |
Carvalho, AF; Hidalgo-Mazzei, D; Murru, A; Pacchiarotti, I; Samalin, L; Verdolini, N; Vieta, E; Young, AH | 1 |
Bergink, V; Brown, HK; D'Onofrio, BM; Di Florio, A; Gomes, T; Howard, LM; Khalifeh, H; Krohn, H; Larsson, H; Lichtenstein, P; Liu, X; Meltzer-Brody, S; Munk-Olsen, T; Taylor, CL; Van Kamp, I; Vigod, SN; Viktorin, A; Wesseloo, R | 1 |
Martino, DJ; Valerio, MP | 1 |
Adli, M; Bopp, SK; Bschor, T; Cichon, S; Heilbronner, U; Heinz, A; Hellweg, R; Herms, S; Köhler, S; Lang, UE; Merkl, A; Mühleisen, TW; Richter, C; Ricken, R; Schlattmann, P; Schulze, TG; Stamm, TJ; Steinacher, B; Sterzer, P | 1 |
Berrocoso, E; González-Saiz, F; Mico, JA; Perez-Caballero, L; Romero-López-Alberca, C; Torres-Sanchez, S | 1 |
Brunkhorst-Kanaan, N; Geisslinger, G; Hackel, J; Hahnefeld, L; Kittel-Schneider, S; Klatt-Schreiner, K; Reif, A; Schröter, K; Tegeder, I; Thomas, D; Trautmann, S; Wicker, S | 1 |
Bauer, M; Dell'osso, L; Dencker Vansvik, E; Jørgensen, L; Kasper, S; Köhler, J; Montgomery, SA; Pitchot, W | 1 |
Benedetti, F; Colombo, C; Dallaspezia, S; Locatelli, C; Poletti, S; Riccaboni, R | 1 |
Angst, J; Bauer, M; Köhler, S; Möller, HJ; Severus, E; Whybrow, PC | 1 |
Bauer, M; Conell, J; Djawid, B; Fülle, M; Goodday, S; Gruber, O; Haussmann, R; Holthoff, V; Jabs, B; Juckel, G; Kittel-Schneider, S; Lewitzka, U; Pfennig, A; Reif, A; Reif-Leonhard, C; Ritter, P; Severus, E; Uhl, I | 1 |
Corruble, E; Costemale-Lacoste, J; Gaillard, R; Mouaffak, F | 1 |
Otter, M; van Amelsvoort, TA | 1 |
Coffey, MJ; Stevens, JR | 1 |
Adli, M; Bauer, F; Bopp, S; Bschor, T; Heinz, A; Hellweg, R; Himmerich, H; Lang, UE; Richter, C; Ricken, R; Schlattmann, P; Stamm, TJ | 1 |
Anghelescu, IG; Correll, CU; Gao, K; Normann, C; Reis, C; Schaffer, A; Solmi, M; van der Loos, ML; Veronese, N; Zaninotto, L | 1 |
Aggio, V; Ambrée, O; Arolt, V; Benedetti, F; Colombo, C; de Wit, H; Drexhage, HA; Hoogenboezem, TA; Locatelli, C; Poletti, S; Wijkhuijs, AJ | 1 |
Luckenbaugh, DA; Niciu, MJ; Pennybaker, SJ; Zarate, CA | 1 |
De-Paula, VJ; Forlenza, OV; Gattaz, WF | 1 |
Allison, S; Bastiampillai, T; Chan, SKW; Gupta, A | 1 |
Brisbane, DS; Cherry, S; Lie, D; Spivak, V; Wysoczanski, D | 1 |
Beaulieu, JM; Bureau, A; Chagnon, YC; Maziade, M; Paccalet, T | 1 |
Adli, M; Baethge, C; Bauer, M; Bschor, T; Ising, M; Lewitzka, U; Lucka, C; Mueller-Oerlinghausen, B; Uhr, M | 1 |
Amsterdam, JD; Shults, J; Wang, G | 1 |
Dwivedi, Y; Pandey, GN; Ren, X; Rizavi, HS | 1 |
Burt, VK; Ritchie, HL; Sharma, V | 1 |
Chilakamarri, G; Weismantel, A; Weismantel, D | 1 |
Nolen, WA; Spijker, J | 1 |
Baldessarini, RJ; Tondo, L; Vázquez, G | 1 |
Haskett, R; Isenberg, K; Kimball, J; Lasater, B; McCall, WV; Prudic, J; Rosenquist, PB; Sackeim, HA | 1 |
Chappell, PB; Gurtovaya, O; Ice, KS; Kasuba, B; Sachs, GS; Schwartz, JH; Vanderburg, DG | 1 |
Bschor, T; Erbe, S; Ising, M; Lewitzka, U; Ritter, D; Uhr, M; Winkelmann, P | 1 |
Albayram, Ö; Bilkei-Gorzo, A; Breuer, R; Cichon, S; Degenhardt, FA; Dreisow, ML; Frank, J; Mattheisen, M; Meier, S; Miró, X; Mühleisen, TW; Nöthen, MM; Pardo-Olmedilla, MT; Reinhard, I; Rietschel, M; Schmäl, C; Seidenbecher, C; Strohmaier, J; Zimmer, A | 1 |
Jackson, WC; Jain, R | 1 |
Brus, O; Carlborg, A; Engström, I; Ljung, T; Nordenskjöld, A; von Knorring, L | 1 |
Cusin, C; Lucca, A; Mandelli, L; Serretti, A; Smeraldi, E | 1 |
Beersma, DG; den Boer, JA; Dols, LC; Mersch, PP; van den Hoofdakker, RH | 1 |
Müller-Oerlinghausen, B; Wolf, T | 1 |
Bowley, MP; Drevets, WC; Ongür, D; Price, JL | 1 |
Alpert, JE; Fava, M; Montoya, HD; Nierenberg, AA; Papakostas, GI; Petersen, T; Tedlow, J; Worthington, JJ | 1 |
Caviness, JN; Evidente, VG | 1 |
Rothschild, AJ | 1 |
Chidori, S; Nishimura, R | 1 |
Kaji, K; Nakamura, J; Yoshimura, R | 1 |
Higuchi, H | 1 |
Bauer, M; Bschor, T | 2 |
Birkenhäger, TK; Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW | 2 |
Klibanski, A; Misra, M; Papakostas, GI | 1 |
Basinski, J; Begley, A; Dew, MA; Farhi, P; Mulsant, BH; Reynolds, CF; Whyte, EM | 1 |
Kobayashi, N; Nomura, S; Sawamura, T; Yoshida, T; Yoshino, A | 1 |
Bares, M; Kopecek, M; Mohr, P | 1 |
Maggini, C; Marchesi, C; Paini, M | 1 |
Henn, FA; Sartorius, A; Wolf, J | 1 |
Bickel, A; Kornhuber, J; Maihöfner, C; Ropohl, A | 1 |
De Pradier, M; Goldberger, C | 1 |
Valenstein, M | 1 |
Birkenhäger, TK; Bruijn, JA; Moleman, P; van den Broek, WW | 1 |
Kvale, JN | 1 |
Cairoli, S; Tosca, P; Zerbi, F | 1 |
Dörr-Zegers, O; Tellenbach, H | 1 |
Alda, M; Deshauer, D; Grof, E; Grof, P | 1 |
Bauer, M; Bschor, T; Canata, B; Müller-Oerlinghausen, B | 1 |
Chen, B; Dowlatshahi, D; MacQueen, GM; Stewart, RJ; Young, LT | 1 |
Cusin, C; Lattuada, E; Lilli, R; Lorenzi, C; Rossini, D; Serretti, A; Smeraldi, E; Zanardi, R | 1 |
Bech, P; Geisler, A; Johannesen, M; Rafaelsen, OJ | 1 |
Freedman, R; Schwab, PJ | 1 |
Boscredon, J; Oulès, J | 1 |
Akiskal, HS; McKinney, WT | 1 |
de Hooge, JK | 1 |
Savitsky, E | 1 |
Edgell, PG; Peterfy, G; Pinter, EJ | 1 |
Nakaya, K; Otsuki, S; Taguchi, K; Watanabe, S | 1 |
Angst, J; Baastrup, PC; Grof, P; Schou, M; Weis, P | 1 |
Náhunek, K; Rodová, A; Svestka, J | 2 |
Bell, GO; Tucker, WI | 1 |
Aimard, G; Chazot, G; Devic, M; Eyssette, M; Fournis, Y | 1 |
Náhunek, K; Novotná, D; Rodová, A; Svestka, J | 1 |
20 review(s) available for lithium and Depressive Disorder, Major
Article | Year |
---|---|
Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients.
Topics: Bipolar Disorder; Depression; Depressive Disorder, Major; Genetic Predisposition to Disease; Humans; Lithium; Multifactorial Inheritance; Risk Factors; Schizophrenia | 2021 |
Bipolar disorders.
Topics: Adolescent; Adult; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Cardiovascular Diseases; Child; Child Abuse; Comorbidity; Depressive Disorder, Major; Environmental Exposure; Humans; Lamotrigine; Lithium; Mania; Suicide; Suicide Prevention; Valproic Acid; Young Adult | 2020 |
Does lithium prevent relapse following successful electroconvulsive therapy for major depression? A systematic review and meta-analysis.
Topics: Depression; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Lithium; Prospective Studies; Recurrence; Retrospective Studies | 2021 |
Pharmacological treatment of adult bipolar disorder.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Humans; Lithium; Lithium Compounds | 2019 |
Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Thiazoles; Valproic Acid | 2018 |
Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies.
Topics: Adult; Bipolar Disorder; Cohort Studies; Depressive Disorder, Major; Europe; Female; Global Health; Humans; Infant, Newborn; Lithium; Ontario; Pregnancy; Pregnancy Complications; United States | 2018 |
Differential response to lithium between melancholic and non-melancholic unipolar depression.
Topics: Adult; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Lithium; Male; Middle Aged; Treatment Outcome | 2018 |
Monoaminergic system and depression.
Topics: Antidepressive Agents; Antipsychotic Agents; Biogenic Monoamines; Buspirone; Depressive Disorder, Major; Drug Synergism; Excitatory Amino Acid Agents; Humans; Lithium; Pindolol; Triiodothyronine | 2019 |
Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Topics: Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Citalopram; Depression; Depressive Disorder, Major; Drug Combinations; Fluoxetine; Humans; Inositol; Lamotrigine; Lithium; Triazines; Vitamin B Complex | 2016 |
Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.
Topics: Adult; Alcohol-Related Disorders; Antidepressive Agents; Bipolar Disorder; Depressive Disorder, Major; Female; Humans; Infusions, Intravenous; Ketamine; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome; Valproic Acid | 2017 |
Assessment and treatment of bipolar II postpartum depression: a review.
Topics: Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Combined Modality Therapy; Depression, Postpartum; Depressive Disorder, Major; Diagnosis, Differential; Drug Therapy, Combination; Evidence-Based Medicine; Female; Humans; Lithium; Mass Screening; Pregnancy; Psychotherapy; Recurrence | 2010 |
Mania associated with antidepressant treatment: comprehensive meta-analytic review.
Topics: Adult; Age Factors; Antidepressive Agents, Tricyclic; Antimanic Agents; Bipolar Disorder; Depressive Disorder, Major; Humans; Lithium; Middle Aged; Models, Statistical; Risk Factors; Selective Serotonin Reuptake Inhibitors; Time Factors | 2010 |
Challenges in the treatment of depression with psychotic features.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Electroconvulsive Therapy; Family; Glucocorticoids; Humans; Hydrocortisone; Lithium; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors | 2003 |
[Mood disorder in childhood and adolescence].
Topics: Bipolar Disorder; Carbamazepine; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Humans; Lithium; Psychotherapy; Psychotropic Drugs; Reference Standards | 2003 |
[Double depression].
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Disease Progression; Drug Therapy, Combination; Fluvoxamine; Humans; Lithium; Male; Middle Aged; Psychotherapy; Reference Standards; Selective Serotonin Reuptake Inhibitors | 2003 |
[Postpsychotic depressive disorder].
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depressive Disorder, Major; Diagnosis, Differential; Drug Therapy, Combination; Humans; Lithium; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors | 2003 |
Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Bone and Bones; Bone Density; Comorbidity; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Hyperprolactinemia; Hypogonadism; Lithium; Male; Mental Disorders; Osteoporosis; Prolactin; Psychotic Disorders; Psychotropic Drugs; Schizophrenia | 2004 |
Efficacy and mechanisms of action of lithium augmentation in refractory major depression.
Topics: Animals; Antidepressive Agents; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium | 2006 |
Overview of recent research in depression. Integration of ten conceptual models into a comprehensive clinical frame.
Topics: Anger; Animals; Anxiety, Separation; Behavior; Bipolar Disorder; Cognition; Depression; Depressive Disorder, Major; Diagnosis, Differential; Disease Models, Animal; Feedback; Happiness; Humans; Lithium; Models, Psychological; Monoamine Oxidase Inhibitors; Prognosis; Research; Self Concept; Stress, Psychological; Terminology as Topic | 1975 |
[Antidepressive agents in the elderly].
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depressive Disorder; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Lithium; Monoamine Oxidase Inhibitors | 1990 |
24 trial(s) available for lithium and Depressive Disorder, Major
Article | Year |
---|---|
Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder: A Randomized Clinical Trial.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Lithium; Male; Middle Aged; Outcome Assessment, Health Care; Suicidal Ideation; Suicide, Attempted; Veterans | 2022 |
Adjunctive lumateperone (ITI-007) in the treatment of bipolar depression: Results from a randomized placebo-controlled clinical trial.
Topics: Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Humans; Lithium; Treatment Outcome; Valproic Acid | 2023 |
Estimating the per-protocol effect of lithium on suicidality in a randomized trial of individuals with depression or bipolar disorder.
Topics: Bipolar Disorder; Depression; Depressive Disorder, Major; Humans; Lithium; Randomized Controlled Trials as Topic; Suicide | 2023 |
Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE Study.
Topics: Aged; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Lithium; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride | 2022 |
Assessing bipolar disorder in the older adult: the GERI-BD toolbox.
Topics: Aged; Antimanic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Geriatric Assessment; Humans; Lithium; Male; Middle Aged; Mood Disorders; Valproic Acid | 2018 |
Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study).
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Cost-Benefit Analysis; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Humans; Lithium; Quetiapine Fumarate | 2017 |
Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Delayed-Action Preparations; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Lithium; Lithium Compounds; Male; Middle Aged; Psychiatric Status Rating Scales; Quetiapine Fumarate; Treatment Outcome; Young Adult | 2013 |
Does lithium reduce acute suicidal ideation and behavior? A protocol for a randomized, placebo-controlled multicenter trial of lithium plus Treatment As Usual (TAU) in patients with suicidal major depressive episode.
Topics: Adult; Clinical Protocols; Depressive Disorder, Major; Female; Humans; Lithium; Male; Middle Aged; Suicidal Ideation; Suicide; Suicide Prevention; Treatment Outcome | 2015 |
Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.
Topics: Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Middle Aged; Nortriptyline; Quality of Life; Time Factors; Venlafaxine Hydrochloride | 2011 |
Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lithium; Male; Middle Aged; Piperazines; Serotonin Antagonists; Thiazoles; Treatment Outcome; Triazines; Valproic Acid; Young Adult | 2011 |
Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Corticotropin-Releasing Hormone; Demography; Depressive Disorder, Major; Dexamethasone; Diagnostic Techniques and Procedures; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Lithium; Male; Middle Aged; Treatment Outcome; Young Adult | 2011 |
Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antimanic Agents; Cognition; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Sample Size; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
The influence of successful prophylactic drug treatment on cognitive dysfunction in bipolar disorders.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Cognition Disorders; Depressive Disorder, Major; Female; Humans; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Remission Induction; Self Concept | 2002 |
Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales | 2003 |
Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluvoxamine; Hospitalization; Humans; Imipramine; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2004 |
Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Geriatric Assessment; Humans; Lithium; Male; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial.
Topics: Adult; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Hospitalization; Humans; Imipramine; Lithium; Male; Middle Aged; Monoamine Oxidase Inhibitors; Outcome Assessment, Health Care; Placebos; Proportional Hazards Models; Psychiatric Status Rating Scales; Risk Factors; Secondary Prevention; Treatment Outcome | 2006 |
Keeping our eyes on STAR*D.
Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Placebos; Research Design; Tranylcypromine; Treatment Outcome; Triiodothyronine; Venlafaxine Hydrochloride | 2006 |
Outcome of a 4-step treatment algorithm for depressed inpatients.
Topics: Adult; Aged; Algorithms; Antidepressive Agents; Clinical Protocols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Electroconvulsive Therapy; Feasibility Studies; Female; Hospitalization; Humans; Lithium; Longitudinal Studies; Male; Middle Aged; Monoamine Oxidase Inhibitors; Patient Compliance; Patient Dropouts; Psychiatric Status Rating Scales; Treatment Outcome | 2006 |
Patterns of DST positivity in remitted affective disorders.
Topics: Adult; Aged; Antimanic Agents; Bipolar Disorder; Cross-Sectional Studies; Depressive Disorder, Major; Dexamethasone; Female; Glucocorticoids; Humans; Hypothalamo-Hypophyseal System; Lithium; Male; Middle Aged; Pituitary-Adrenal System; Remission Induction; Seasons; Severity of Illness Index | 1999 |
Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Second-Generation; Antimanic Agents; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Female; Fluvoxamine; Genotype; Humans; Lithium; Male; Middle Aged; Monoamine Oxidase; Paroxetine; Pindolol; Polymorphism, Genetic; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Sex Characteristics | 2002 |
Psychopharmacology in the aged. Discussion.
Topics: Age Factors; Aged; Amitriptyline; Antipsychotic Agents; Bipolar Disorder; Brain Damage, Chronic; Depressive Disorder, Major; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hospital Design and Construction; Hospitals, Psychiatric; Humans; Informed Consent; Lithium; Male; Mental Disorders; Perphenazine; Personality; Placebos; Psychopharmacology | 1974 |
Lithium prophylaxis in recurrent affective disorders.
Topics: Adolescent; Adult; Affective Symptoms; Aged; Bipolar Disorder; Child; Clinical Trials as Topic; Depression; Depressive Disorder, Major; Female; Humans; Lithium; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychotic Disorders; Statistics as Topic | 1970 |
To the antidepressive properties of lithium and its place in the group of antidepressive drugs.
Topics: Antidepressive Agents; Bipolar Disorder; Carbonates; Clinical Trials as Topic; Coma; Depression; Depressive Disorder, Major; History, 15th Century; History, 16th Century; History, 17th Century; History, 18th Century; Humans; Hypnotics and Sedatives; Lithium; Movement Disorders; Placebos; Pruritus; Psychiatric Status Rating Scales | 1971 |
66 other study(ies) available for lithium and Depressive Disorder, Major
Article | Year |
---|---|
A GWAS top hit for circulating leptin is associated with weight gain but not with leptin protein levels in lithium-augmented patients with major depression.
Topics: Body Mass Index; Depression; Depressive Disorder, Major; Genome-Wide Association Study; Humans; Leptin; Lithium; Polymorphism, Single Nucleotide; Weight Gain | 2021 |
A letter to the editor, associated with the article entitled "Efficacy and tolerability of combination treatments for major depression: Antidepressants plus second-generation antipsychotics vs esketamine vs lithium" by Vázquez et al. (
Topics: Antidepressive Agents; Antipsychotic Agents; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Ketamine; Lithium; Psychopharmacology | 2022 |
Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach - CORRIGENDUM.
Topics: Bipolar Disorder; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Humans; Lithium; Machine Learning | 2022 |
Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway.
Topics: Animals; Antidepressive Agents; Depressive Disorder, Major; Ketamine; Lithium; Lithium Compounds; Male; Mammals; Mania; Mice; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Rodent Diseases; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Inflammation and damage-associated molecular patterns in major psychiatric disorders.
Topics: Bipolar Disorder; Clozapine; Depressive Disorder, Major; HSP70 Heat-Shock Proteins; Humans; Inflammation; Lithium | 2023 |
Lumateperone Normalizes Pathological Levels of Acute Inflammation through Important Pathways Known to Be Involved in Mood Regulation.
Topics: Animals; Cytokines; Depressive Disorder, Major; Female; Inflammation; Lithium; Male; Mammals; Mice; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; TOR Serine-Threonine Kinases; Valproic Acid | 2023 |
When and How to Use Lithium Augmentation for Treating Major Depressive Disorder.
Topics: Antidepressive Agents; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium; Lithium Carbonate | 2023 |
Electroconvulsive therapy plus lithium is associated with less cognitive impairment and drug-induced delirium in bipolar depression compared to unipolar depression.
Topics: Adult; Bipolar Disorder; Cognitive Dysfunction; Delirium; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Lithium; Treatment Outcome | 2023 |
Association of Bipolar Disorder Diagnosis With Suicide Mortality Rates in Adolescents in Sweden.
Topics: Adolescent; Bipolar Disorder; Cross-Sectional Studies; Depressive Disorder, Major; Female; Humans; Lithium; Male; Suicide; Sweden | 2023 |
Lithium treatment versus hospitalization in bipolar disorder and major depression patients.
Topics: Bipolar Disorder; Depression; Depressive Disorder, Major; Hospitalization; Humans; Lithium; Lithium Compounds; Retrospective Studies; Substance-Related Disorders | 2023 |
Polygenic risk scores of lithium response and treatment resistance in major depressive disorder.
Topics: Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Electroconvulsive Therapy; Humans; Lithium | 2023 |
Re: "The Impact of Placebo Response Rates on Clinical Trial Outcome: A Systematic Review and Meta-Analysis of Antidepressants in Children and Adolescents with Major Depressive Disorder" by Li Y, Huang J, He Y, Yang J, Lv Y, Liu H, Liang L, Zheng Q, and Li
Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Humans; Lithium; Male; Placebo Effect | 2020 |
Association of polygenic score for major depression with response to lithium in patients with bipolar disorder.
Topics: Bipolar Disorder; Depression; Depressive Disorder, Major; Genome-Wide Association Study; Humans; Lithium | 2021 |
Mesocortical BDNF signaling mediates antidepressive-like effects of lithium.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Lithium; Mice; Nucleus Accumbens; Prefrontal Cortex; Ventral Tegmental Area | 2020 |
Differential acute impact of therapeutically effective and overdose concentrations of lithium on human neuronal single cell and network function.
Topics: Action Potentials; Depressive Disorder, Major; Humans; Induced Pluripotent Stem Cells; Lithium; Neurons | 2021 |
Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium response.
Topics: Biomarkers; Cross-Sectional Studies; Depressive Disorder, Major; Glial Cell Line-Derived Neurotrophic Factor; Humans; Lithium; Mood Disorders | 2021 |
Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Antipsychotic Agents; Clozapine; Cohort Studies; Depressive Disorder; Depressive Disorder, Major; Female; Finland; Humans; Incidence; Lithium; Male; Middle Aged; Outcome Assessment, Health Care; Patient Readmission; Risk; Secondary Prevention; Severity of Illness Index | 2017 |
Lithium for long-term treatment of unipolar depression.
Topics: Bipolar Disorder; Cohort Studies; Depressive Disorder, Major; Finland; Humans; Lithium; Patient Readmission | 2017 |
Use of lithium in patients with unipolar depression.
Topics: Bipolar Disorder; Cohort Studies; Depressive Disorder, Major; Finland; Humans; Lithium; Patient Readmission | 2017 |
Use of lithium in patients with unipolar depression - Author's reply.
Topics: Cohort Studies; Depressive Disorder, Major; Finland; Humans; Lithium; Patient Readmission | 2017 |
Ghrelin Serum Concentrations Are Associated with Treatment Response During Lithium Augmentation of Antidepressants.
Topics: Adult; Aged; Antidepressive Agents; Body Mass Index; Cohort Studies; Depressive Disorder, Major; Female; Ghrelin; Humans; Lithium; Male; Middle Aged; Time Factors | 2017 |
Leptin gene polymorphisms are associated with weight gain during lithium augmentation in patients with major depression.
Topics: Adult; Depressive Disorder, Major; Female; Genotype; Humans; Ideal Body Weight; Leptin; Lithium; Male; Middle Aged; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Retrospective Studies; Weight Gain | 2019 |
Targeted lipidomics reveal derangement of ceramides in major depression and bipolar disorder.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Body Mass Index; Ceramides; Depressive Disorder, Major; Diglycerides; Female; Humans; Lipid Metabolism; Lithium; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Sex Characteristics; Triglycerides; Young Adult | 2019 |
Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Chronotherapy; Combined Modality Therapy; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Resistance; Female; Humans; Lithium; Male; Middle Aged; Phototherapy; Severity of Illness Index; Sleep Deprivation; Suicide Prevention; Time Factors; Treatment Outcome | 2014 |
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015.
Topics: Antidepressive Agents; Antipsychotic Agents; Biological Psychiatry; Carbamazepine; Depressive Disorder, Major; Dibenzothiazepines; Drug Therapy, Combination; Electroconvulsive Therapy; Evidence-Based Medicine; Humans; Lithium; Plant Extracts; Psychotherapy; Quetiapine Fumarate | 2015 |
Is Polyuria a Predictive Sign of Lithium Response in Major Depression?
Topics: Depressive Disorder, Major; Humans; Lithium; Polyuria; Predictive Value of Tests; Treatment Outcome | 2015 |
[Lithium therapy in patients with mild mental retardation].
Topics: Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Comorbidity; Depressive Disorder, Major; Disability Evaluation; Female; Humans; Intellectual Disability; Lithium; Mental Health Services; Middle Aged; Severity of Illness Index; Treatment Outcome; Young Adult | 2015 |
Safe and Successful ECT in a Female-to-Male Transgender Individual With Major Depression.
Topics: Adult; Antimanic Agents; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Psychiatric Status Rating Scales; Sex Reassignment Procedures; Suicidal Ideation; Transgender Persons | 2016 |
Leptin serum concentrations are associated with weight gain during lithium augmentation.
Topics: Adult; Aged; Body Mass Index; Body Weight; Cohort Studies; Depressive Disorder, Major; Female; Humans; Leptin; Lithium; Male; Middle Aged; Obesity; Prospective Studies; Weight Gain | 2016 |
Brain-derived Neurotrophic Factor (BDNF) and gray matter volume in bipolar disorder.
Topics: Adult; Biomarkers; Bipolar Disorder; Brain; Brain-Derived Neurotrophic Factor; Case-Control Studies; Cerebral Cortex; Depressive Disorder, Major; Female; Gray Matter; Gyrus Cinguli; Humans; Lithium; Male; Middle Aged | 2017 |
Long-term lithium treatment increases intracellular and extracellular brain-derived neurotrophic factor (BDNF) in cortical and hippocampal neurons at subtherapeutic concentrations.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cerebral Cortex; Depressive Disorder, Major; Disease Models, Animal; Hippocampus; Lithium; Long Term Adverse Effects; Neurons; Neuroprotective Agents; Rats | 2016 |
Lithium, suicide prevention and unipolar depression?
Topics: Antimanic Agents; Bipolar Disorder; Depressive Disorder, Major; Humans; Lithium; Suicide | 2017 |
Lithium augmentation as an alternative to maintenance electroconvulsive therapy for recurrent major depressive disorder in older adults.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Treatment Outcome | 2017 |
The interaction of GSK3B and FXR1 genotypes may influence the mania and depression dimensions in mood disorders.
Topics: Adult; Age of Onset; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Genotype; Glycogen Synthase Kinase 3 beta; Humans; Lithium; Male; Middle Aged; Mood Disorders; Polymorphism, Genetic; Prevalence; RNA-Binding Proteins | 2017 |
Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity.
Topics: Adrenocorticotropic Hormone; Corticotropin-Releasing Hormone; Depressive Disorder, Major; Dexamethasone; Female; Follow-Up Studies; Glucocorticoids; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Lithium; Male; Middle Aged; Pituitary-Adrenal System; Psychotropic Drugs; Recurrence; Time Factors; Treatment Outcome | 2009 |
Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Female; Humans; Lithium; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2010 |
Glycogen synthase kinase-3beta in the platelets of patients with mood disorders: effect of treatment.
Topics: Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Blood Platelets; Cell Membrane; Cytosol; Depressive Disorder, Major; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lithium | 2010 |
Can nonantidepressants help treat depression?
Topics: Antidepressive Agents; Antipsychotic Agents; Cohort Studies; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Triiodothyronine | 2009 |
An algorithm for the pharmacological treatment of depression.
Topics: Algorithms; Antidepressive Agents; Antimanic Agents; Combined Modality Therapy; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Electroconvulsive Therapy; Humans; Lithium; MEDLINE; Meta-Analysis as Topic; Monoamine Oxidase Inhibitors; Netherlands; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 2010 |
Studies in humans and mice implicate neurocan in the etiology of mania.
Topics: Alleles; Animals; Behavior, Animal; Bipolar Disorder; Depressive Disorder, Major; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Lithium; Male; Mice; Mice, Knockout; Neurocan; Principal Component Analysis; Schizophrenia | 2012 |
Beyond the resistance: how novel neurobiological understandings of depression may lead to advanced treatment strategies.
Topics: Adult; Alleles; Antidepressive Agents; Brain; Coenzymes; Controlled Clinical Trials as Topic; Cytokines; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; DNA Mutational Analysis; Drug Therapy, Combination; Genetic Predisposition to Disease; Humans; Inflammation Mediators; Lithium; Magnetic Resonance Imaging; Methylenetetrahydrofolate Reductase (NADPH2); Nerve Growth Factors; Obesity; Obesity, Abdominal; Polymorphism, Genetic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Tetrahydrofolates; Waist Circumference | 2012 |
Seasonal variations of lithium plasma levels.
Topics: Adult; Bipolar Disorder; Depressive Disorder, Major; Erythrocytes; Female; Humans; Lithium; Male; Middle Aged; Seasons | 2002 |
Lithium concentrations in plasma of lithium-treated psychiatric patients in the Netherlands: commentary on Cusin et al.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Female; Humans; Italy; Lithium; Male; Netherlands; Seasons | 2002 |
Low glial numbers in the amygdala in major depressive disorder.
Topics: Amygdala; Anticonvulsants; Bipolar Disorder; Cell Count; Cell Size; Depressive Disorder, Major; Entorhinal Cortex; Humans; Lithium; Neuroglia; Neurons; Valproic Acid | 2002 |
Cortical myoclonus during lithium exposure.
Topics: Adult; Aged; Bipolar Disorder; Cerebral Cortex; Depressive Disorder, Major; Electroencephalography; Electromyography; Female; Humans; Lithium; Male; Middle Aged; Myoclonus; Retrospective Studies | 2003 |
Is successful lithium augmentation limited to serotonergic antidepressants?
Topics: Antimanic Agents; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium; Selective Serotonin Reuptake Inhibitors; Treatment Failure | 2004 |
The effectiveness of lithium augmentation of milnacipran: preliminary data using the modified Japanese Psychopharmacology Algorithm.
Topics: Adrenergic Uptake Inhibitors; Algorithms; Antidepressive Agents; Cyclopropanes; Depressive Disorder, Major; Drug Synergism; Female; Humans; Lithium; Male; Milnacipran; Selective Serotonin Reuptake Inhibitors | 2004 |
Ziprasidone-induced galactorrhea: a case report.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Clonazepam; Depressive Disorder, Major; Female; Galactorrhea; Humans; Lithium; Piperazines; Prolactin; Recurrence; Thiazoles | 2005 |
Severe diurnal somnolence induced by fluvoxamine-lithium combination.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Disorders of Excessive Somnolence; Drug Therapy, Combination; Fluvoxamine; Humans; Lithium; Male | 2005 |
Lithium and ECT--concurrent use still demands attention: three case reports.
Topics: Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Blood-Brain Barrier; Combined Modality Therapy; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Middle Aged | 2005 |
Exacerbation of migraine attacks during treatment with the selective serotonin reuptake inhibitor sertraline. A case report.
Topics: Adrenergic beta-Antagonists; Antimanic Agents; Depressive Disorder, Major; Female; Humans; Lithium; Metoprolol; Middle Aged; Migraine Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline | 2005 |
[Major depressive disorder in personality disorder].
Topics: Adult; Antimanic Agents; Depressive Disorder, Major; Female; Humans; Lithium; Personality Disorders; Severity of Illness Index | 2005 |
Psychoactive drugs and the frail elderly patient.
Topics: Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Anxiety Disorders; Delirium; Depressive Disorder; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Electroconvulsive Therapy; Humans; Lithium; Mood Disorders; Psychotherapy; Psychotropic Drugs; Sleep Wake Disorders | 1984 |
[Various aspects and problems of depression in the aged].
Topics: Aged; Aging; Antidepressive Agents, Tricyclic; Brain; Depressive Disorder, Major; Heart; Humans; Lithium; Organ Size | 1984 |
[Differential phenomenology of depressive states (author's transl)].
Topics: Adult; Bipolar Disorder; Depressive Disorder; Depressive Disorder, Major; Epilepsy; Female; Humans; Lithium; Male; Middle Aged | 1980 |
Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Antimanic Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Forecasting; Humans; Lithium; Male; Middle Aged; Retrospective Studies | 2001 |
Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium.
Topics: Adenylyl Cyclases; Antidepressive Agents; Archives; Bipolar Disorder; Calcium-Calmodulin-Dependent Protein Kinases; Cerebral Cortex; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Depressive Disorder, Major; GTP-Binding Proteins; Humans; Immunoblotting; Lithium; Neurons; Signal Transduction; Tissue Banks | 2001 |
Cyclic AMP levels in cerebrospinal fluid in manic-melancholic patients.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Bipolar Disorder; Cyclic AMP; Depression; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Tranquilizing Agents | 1976 |
Paranoid symptoms in patients on a general hospital psychiatric unit. Implications for diagnosis and treatment.
Topics: Adult; Affective Disorders, Psychotic; Antidepressive Agents; Bipolar Disorder; Delusions; Depressive Disorder, Major; Diagnosis, Differential; Diagnostic Errors; Female; Hospitals, General; Humans; Lithium; Male; Middle Aged; Neurocognitive Disorders; Paranoid Behavior; Paranoid Disorders; Psychiatric Department, Hospital; Psychotherapy; Schizophrenia, Paranoid | 1978 |
[Treatment of drug-resistant depressive states with lithium gluconate].
Topics: Adjustment Disorders; Aged; Bipolar Disorder; Depression; Depressive Disorder, Major; Female; Humans; Lithium; Male; Middle Aged | 1977 |
Lithium toxicity.
Topics: Aged; Depression; Depressive Disorder, Major; Female; Humans; Lithium | 1970 |
Clinical effects of lithium carbonate on depression.
Topics: Adolescent; Adult; Affective Symptoms; Bipolar Disorder; Carbonates; Depression; Depressive Disorder, Major; Female; Humans; Lithium; Male; Middle Aged | 1973 |
Effectiveness of lithium carbonate in the prevention of manic and depressive episodes.
Topics: Adult; Bipolar Disorder; Carbonates; Depressive Disorder, Major; Female; Humans; Hypothyroidism; Lithium; Male; Middle Aged; Recurrence; Schizophrenia; Thyroid Gland; Thyroid Hormones | 1972 |
[Lithium in depressive conditions. A trial in 150 cases during 18 months].
Topics: Adjustment Disorders; Adult; Age Factors; Aged; Bipolar Disorder; Depression; Depressive Disorder, Major; Drug Tolerance; Female; Gluconates; Humans; Lithium; Male; Middle Aged; Sodium Chloride | 1972 |
[Recurrence of psychoses in preventive lithium therapy].
Topics: Bipolar Disorder; Chronic Disease; Depression; Depressive Disorder, Major; Humans; Lithium; Psychotic Disorders; Schizophrenia; Time Factors | 1970 |
[Prophylactic administration of lithium carbonate in affective psychoses].
Topics: Adult; Age Factors; Aged; Bipolar Disorder; Depressive Disorder, Major; Female; Hospitalization; Humans; Lithium; Male; Middle Aged; Time Factors | 1971 |